Linking micro- and nanoplastic hepatic signatures to immune reprogramming along the MASH-to-HCC continuum: development and cross-cohort validation of a transcriptomic signature
Translational Gastroenterology and Hepatology · 2026-11 · 11 · 136-136
DOI: 10.21037/tgh-2026-0176 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Gastroenterology and Hepatology, 2026-11. Verfasst von Hao Ling und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Micro- and nanoplastics (MNPs) disrupt intestinal barrier integrity and microbial homeostasis, but the molecular pathways linking chronic exposure to premalignant hepatic immune reprogramming remain unclear. We constructed a cross-species, multi-resolution systems toxicology evidence chain to test whether an MNP-derived transcriptomic signature recapitulates metabolic-dysfunction-associated steatohepatitis (MASH)-to-hepatocellular carcinoma (HCC) progression.
Methods
An immune/metabolic-downregulated signature from MNP-exposed mouse livers was projected onto an independent MASH single-cell atlas and three human HCC cohorts.
Results
Single-cell analysis revealed coordinated intrahepatic immune reprogramming that scaled with disease severity, including expansion of monocyte-derived macrophages (MoMFs) (ρ=0.85), loss of Kupffer cell identity (ρ=−0.78), and T-cell exhaustion (ρ=0.61). Scar-associated macrophages (SAMs) emerged as a dominant immunosuppressive hub, with predicted Cxcl16-Cxcr6 communication 5.9-fold higher in MASH than in healthy liver. MNP-induced metabolic perturbations mirrored MASH severity (cholesterol ρ=−0.87), whereas interferon and antigen-presentation programs were blunted and reproduced in an independent oral-MNP cohort. A controlled oral-MNP exposure cohort provided a direct exposure-versus-control contrast, showing size-dependent Kupffer-cell reprogramming toward an M2-like transcriptional state (M2 program increased, P=0.01; reduced phagocytic capacity reported by the source study), and immune-signature downregulation was observed in three of four exposure contrasts from three independent MNP datasets, with the strongest decrease in the evaluated MASH-background contrast. The signature carried no independent prognostic value, its survival association being explained by immune infiltration; bulk deconvolution could not resolve macrophage compositional shifts; and portal-vein metabolomics remains a key data gap.
Conclusions
This evidence-graded framework identifies Kupffer-cell reprogramming as the strongest exposure-linked node and defines paired portal-versus-systemic metabolite profiling as the priority validation experiment. This study follows a prespecified signature development and external validation design, and the resulting transcriptomic signature primarily tracks total intra-tumoral immune infiltration rather than exerting independent prognostic value.
Zitieren
APA
Ling, H., Hu, Y., & Sun, Y. (2026). Linking micro- and nanoplastic hepatic signatures to immune reprogramming along the MASH-to-HCC continuum: development and cross-cohort validation of a transcriptomic signature. Translational Gastroenterology and Hepatology, 11, 136-136. https://doi.org/10.21037/tgh-2026-0176
Vancouver
Ling H, Hu Y, Sun Y. Linking micro- and nanoplastic hepatic signatures to immune reprogramming along the MASH-to-HCC continuum: development and cross-cohort validation of a transcriptomic signature. Translational Gastroenterology and Hepatology. 2026;11:136-136. doi:10.21037/tgh-2026-0176
BibTeX
@article{Ling2026,
author = {Ling, Hao and Hu, Yanzhu and Sun, Yan},
title = {Linking micro- and nanoplastic hepatic signatures to immune reprogramming along the MASH-to-HCC continuum: development and cross-cohort validation of a transcriptomic signature},
journal = {Translational Gastroenterology and Hepatology},
year = {2026},
volume = {11},
pages = {136--136},
doi = {10.21037/tgh-2026-0176}
}
EUVIMED